TITLE

Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy

AUTHOR(S)
Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B.
PUB. DATE
October 2013
SOURCE
PLoS ONE;Oct2013, Vol. 8 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI) and death. Methods: A Canadian cohort of HIV-positive adults with CD4:CD8<1.2 prior to starting cART from 2000–2010 were analyzed. Predictors of (1) reaching a CD4:CD8 ≥1.2 on two separate follow-up visits >30 days apart, and (2) ADI and death from all causes were assessed using adjusted proportional hazards models. Results: 4206 patients were studied for a median of 2.77 years and 306 (7.2%) normalized their CD4:CD8 ratio. Factors associated with achieving a normal CD4:CD8 ratio were: baseline CD4+ T-cells >350 cells/mm3, baseline CD8+ T-cells <500 cells/mm3, time-updated HIV RNA suppression, and not reporting sex with other men as a risk factor. There were 213 ADIs and 214 deaths in 13476 person-years of follow-up. Achieving a normal CD4:CD8 ratio was not associated with time to ADI/death. Conclusions: In our study, few individuals normalized their CD4:CD8 ratios within the first few years of initiating modern cART. This large study showed no additional short-term predictive value of the CD4:CD8 ratio for clinical outcomes after accounting for other risk factors including age and HIV RNA.
ACCESSION #
94479488

 

Related Articles

  • Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio. Serrano-Villar, Sergio; Pérez-Elías, María Jesús; Dronda, Fernando; Casado, José Luis; Moreno, Ana; Royuela, Ana; Pérez-Molina, José Antonio; Sainz, Talia; Navas, Enrique; Hermida, José Manuel; Quereda, Carmen; Moreno, Santiago // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: A low CD4/CD8 ratio has been identified in the general population as a hallmark of inmmunosenescence and a surrogate of all-cause mortality. We aimed to investigate in treated HIV-infected individuals the relationship between the CD4/CD8 ratio and serious non-AIDS events. Methods:...

  • CD28-Negative CD4+ and CD8+ T Cells in Antiretroviral Therapy–Naive HIV-Infected Adults Enrolled in Adult Clinical Trials Group Studies. Tassiopoulos, Katherine; Landay, Alan; Collier, Ann C.; Connick, Elizabeth; Deeks, Steven G.; Hunt, Peter; Lewis, Dorothy E.; Wilson, Cara; Bosch, Ronald // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 11, p1730 

    Background Individuals infected with human immunodeficiency virus (HIV) have higher risk than HIV-negative individuals for diseases associated with aging. T-cell senescence, characterized by expansion of cells lacking the costimulatory molecule CD28, has been hypothesized to mediate these risks....

  • Determinants of Antiretroviral Therapy Initiation and Treatment Outcomes for People Living With HIV in Vietnam. Tran, Dam Anh; Shakeshaft, Anthony; Ngo, Anh Duc; Mallitt, Kylie-Ann; Wilson, David; Doran, Christopher; Lei Zhang // HIV Clinical Trials;Jan/Feb2013, Vol. 14 Issue 1, p21 

    Objectives: This study explores patient characteristics that are significantly associated with very late combination antiretroviral therapy (cART) initiation (CD4 count ≤100 cells/mm³) and examines the association between patient characteristics and treatment outcomes, CD4 recovery, and...

  • CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy. Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah; Crowe, Suzanne M.; Landay, Alan L.; Cheng, Ben; Barnett, David; Denny, Thomas N.; Spira, Thomas J.; Stevens, Wendy S.; Crowley, Siobhan; Essajee, Shaffiq; Vitoria, Marco; Ford, Nathan // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, particularly in determining eligibility to initiate antiretroviral treatment (ART). A number of technologies exist for CD4 enumeration, with considerable variation in cost, complexity,...

  • Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals. Kløverpris, Henrik N.; Jackson, Akil; Handley, Amanda; Hayes, Peter; Gilmour, Jill; Riddell, Lynn; Chen, Fabian; Atkins, Mark; Boffito, Marta; Walker, Bruce D.; Ackland, Jim; Sullivan, Mark; Goulder, Philip // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: HIV Gag-specific CD4+ and CD8+ T-cell responses are important for HIV immune control. Pulsing overlapping Gag peptides on autologous lymphocytes (OPAL) has proven immunogenic and effective in reducing viral loads in multiple pigtail macaque studies, warranting clinical evaluation....

  • Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study. De Salvador-Guillouët, F.; Sakarovitch, C.; Durant, J.; Risso, K.; Demonchy, E.; Roger, P. M.; Fontas, E. // PLoS ONE;10/20/2015, Vol. 10 Issue 10, p1 

    Background: As CD4/CD8 ratio inversion has been associated with non-AIDS morbidity and mortality, predictors of ratio normalization after cART need to be studied. Here, we aimed to investigate the association of antiretroviral regimens with CD4/CD8 ratio normalization within an observational...

  • Maintaining Patients on a Failing Antiretroviral Regimen Reduces the Risk of AIDS-defining Events. Winslow, Dean L. // Infectious Disease Alert;Mar2009, Vol. 28 Issue 6, p28 

    For this study, 12,765 patients from the large French Hospital Database for HIV with CD4+ lymphocyte counts < 200 cells/uL who received cART during 2000-2005 were selected. Three groups of patients were identified: patients who interrupted cART at least once, patients with detectable HIV RNA...

  • Retrospective Analysis of Suspending HAART in Selected Patients with Controlled HIV Replication. Jacobs, Benjamin; Neil, Nancy; Aboulafia, David M. // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p429 

    We sought to determine the consequences of stopping highly active antiretroviral therapy (HAART) in a group of 41 HIV-infected individuals with undetectable HIV viral loads and CD4+ counts greater than 500 cells per microliter for 6 months or more. Clinical and laboratory parameters were...

  • Early Initiation of ART Produces Better Clinical Outcomes.  // Clinical Infectious Diseases;4/15/2009, Vol. 48 Issue 8, following p1167 

    The article presents the results of 2 clinical trials related to effectiveness of antiretroviral therapy on acquired immuno deficiency syndrome (AIDS) patients. The results of North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) state that the antiretroviral naive...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics